Financials
- Market Capitalization 1.96 B
- Employee 136
- Founded 2013
- CEO N/A
- Website www.amylyx.com
- Headquarter Delaware, United States
- FIGI BBG00DP10YT5
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-7.9
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2000 | VRDN Viridian Therapeutics, Inc. - Common Stock | 19.10 USD | +0.58% | -2.05% | +15.20% | -14.92% | 1.97 B USD | ||
| 2008 | TYRA Tyra Biosciences, Inc. - Common Stock | 32.00 USD | -2.05% | +3.66% | +17.69% | +123.15% | 1.90 B USD | ||
| 2014 | URGN UroGen Pharma Ltd. - Ordinary Shares | 39.55 USD | +0.10% | +6.00% | +33.84% | +108.16% | 1.93 B USD | ||
| 2028 | NBTX Nanobiotix S.A. - ADSs | 41.80 USD | +6.77% | +10.61% | +12.37% | +678.40% | 2.02 B USD |